High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Yu Ching ^a   Statt, Sarah ^b   Wu, Reen ^b   Chang, Hao Teng ^a   Liao, Jiunn Wang ^c   Wang, Chien Neng ^a   Shyu, Woei Cherng ^a   Lee, Chen Chen ^a,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3BETA; GSK3B PROTEIN, HUMAN; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; PROTEIN KINASE B; TUMOR ANTIGEN;

CELL LINE; CELL MOTION; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; METABOLISM; PHYSIOLOGY; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

ANTIGENS, NEOPLASM; BETA CATENIN; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3 BETA; HMGB1 PROTEIN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION;

EID: 84954487682     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18815     Document Type: Article

References (60)

1. Kalluri, R., Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
2. Zeisberg, M., Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 119, 1558-8238 (Electronic) (2009).
3. Bartis, D., Mise, N., Mahida, R. Y., Eickelberg, O., Thickett, D. R. Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important Thorax 69, 760-765 (2014).
4. Pain, M. et al. Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. Eur. Respir. Rev. 23, 118-130 (2014).
5. Sidhu, S. S. et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl. Acad. Sci. USA 107, 14170-14175 (2010).
6. Heijink, I. H. et al. Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptordependent Th2 cell-promoting activity. J. Immunol 178, 7678-7685 (2007).
7. Bergeron, C., Al-Ramli, W., Hamid, Q. Remodeling in Asthma. Pro. Am. Thorac. Soc. 6, 301-305 (2009).
8. Chakir, J. et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111, 1293-1298 (2003).
9. Hackett, T. L. Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr. Opin. Allergy Clin. Immunol. 12, 53-59 (2012).
10. Milara, J., Peiro, T., Serrano, A., Cortijo, J. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 68, 410-420 (2013).
11. Davies, D. E. The role of the epithelium in airway remodeling in asthma. Proc. Am. Thorac. Soc. 6, 678-682 (2009).
12. Shifren A., Witt, C., Christie, C. M. C. Mechanisms of Remodeling in Asthmatic Airways. J. Allergy 2012 (2012).
13. Goleva, E., Hauk, P. J., Boguniewicz, J., Martin, R. J., Leung, D. Y. Airway remodeling and lack of bronchodilator response in steroidresistant asthma. J. Allergy Clin. Immunol. 120, 1065-1072 (2007).
14. Holgate, S. T. et al. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J. Allergy Clin. Immunol. 117, 496-506 (2006).
15. Goodwin, G. H., Sanders, C., Johns, E. W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 38, 14-19 (1973).
16. Andersson, U. et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570 (2000).
17. Kokkola, R. et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1-9 (2005).
18. Park, J. S. et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol.Cell Physiol. 284, C870-879 (2003).
19. Watanabe, T. et al. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir. Med. 105, 519-525 (2011).
20. Ferhani, N. et al. Expression of high mobility group box1 and receptor for advanced glycation end products in COPD. Am. J. Respir. Crit. Care Med 181, 917-927 (2010).
21. Lee, C. C. et al. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem. Pharmacol. 86, 940-949 (2013).
22. Lee, C. C., Wang, C. N., Lee, Y. L., Tsai, Y. R., Liu, J. J. High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of mmp-9. PLoS One 10, e0116393 (2015).
23. Zeisberg, M., Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. The Journal of clinical investigation 119, 1429-1437 (2009).
24. Roy, S. et al. Significance of PELP1 in ER-negative breast cancer metastasis. Mol. Cancer Res. 10, 25-33 (2012).
25. Doerner, A. M., Zuraw, B. L. TGF-(1 )induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1 but not abrogated by corticosteroids. Respir. Res. 10, 100-100 (2009).
26. Erzurum, S. C. Inhibition of Tumor Necrosis Factor for Refractory Asthma. N. Engl. J. Med. 354, 754-758 (2006).
27. Camara, J., Jarai, G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis Tissue Repair 3, 2 (2010).
28. Kalluri, R., Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin.Invest. 119, 1420-1428 (2009).
29. Manning, B. D., Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274 (2007).
30. Zheng, H. et al. Glycogen synthase kinase-3 beta regulates Snail and beta-catenin expression during Fas-induced epithelialmesenchymal transition in gastrointestinal cancer. Eur. J. Cancer 49, 2734-2746 (2013).
31. Wang, H., Ward, M. F., Sama, A. E. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock 32, 348-357 (2009).
32. Yang, H., Wang, H., Christopher, J. C., Tracey, K. J. The cytokine activity of HMGB1. J. Leuko. Biol. 78, 1-8 (2005).
33. Ivanov, S. et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110, 1970-1981 (2007).
34. Churg, A., Tai, H., Coulthard, T., Wang, R., Wright, J. L. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am. J. Respir. Crit. Care Med. 174, 1327-1334 (2006).
35. Heijink, I. H., Postma, D. S., Noordhoek, J. A., Broekema, M., Kapus, A. House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am. J. Respir. Cell Mol. Biol. 42, 69-79 (2010).
36. Mikami, Y. et al. Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells. Biochem. Biophys. Res. Commun. 428, 451-457 (2012).
37. Hou, C. et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol. Med. 17, 807-815 (2011).
38. Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480 (2006).
39. Polyak, K., Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273 (2009).
40. Anastas, J. N., Moon, R. T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11-26 (2013).
41. Itou, J. et al. HMGB factors are required for posterior digit development through integrating signaling pathway activities. Developmental Dynamics .240, 1151-1162 (2011).
42. Zeng, X. et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438, 873-877 (2005).
43. Wu, Z. et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir. Res. 8, 1 (2007).
44. Furukawa, M., Wheeler, S., Clark, A. M., Wells, A. Lung Epithelial Cells Induce Both Phenotype Alteration and Senescence in Breast Cancer Cells. PLoS ONE 10, e0118060 (2015).
45. Buckley, S. T., Ehrhardt, C. The receptor for advanced glycation end products (RAGE) and the lung. J. Biomed. Biotechnol. 2010, 917108 (2010).
46. Toure, F. et al. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem. J. 416, 255-261 (2008).
47. Palumbo, R. et al. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-B activation. J. Cell. Biol. 179, 33-40 (2007).
48. Huttunen, H. J., Fages, C., Rauvala, H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924 (1999).
49. Cohen, L. et al. Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am. J. Respir. Crit. Care Med. 176, 138-145 (2007).
50. Hamada, N. et al. The role of high mobility group box1 in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 39, 440-447 (2008).
51. Hou, C. et al. HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol. Immunol. 12, 409-423 (2015).
52. Wang, H. L. et al. HMGB1 enhances smooth muscle cell proliferation and migration in pulmonary artery remodeling. Int. J. Clin. Exp. Pathol. 7, 3836-3844 (2014).
53. Zabini, D. et al. High-mobility group box-1 induces vascular remodelling processes via c-Jun activation. J .Cell Mol. Med. (2015).
54. Fujisawa, T. et al. NF-kappaB mediates IL-1beta-and IL-17A-induced MUC5B expression in airway epithelial cells. Am. J. Respir. Cell Mol .Biol. 45, 246-252 (2011).
55. Yang, H. et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. .Natl. Acad. Sci. 107, 11942-11947 (2010).
56. Zhou, Y. et al. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum. Immunol. 73, 1171-1174 (2012).
57. Rao, Y. K. et al. Ovatodiolide inhibits the maturation of allergen-induced bone marrow-derived dendritic cells and induction of Th2 cell differentiation. Int. immunopharmacol. 17, 617-624 (2013).
58. Lin, C. D. et al. Zinc oxide nanoparticles impair bacterial clearance by macrophages. Nanomedicine 9, 1327-1339 (2014).
59. Anders, S., Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
60. Lee, C. C. et al. Antiallergic asthma properties of brazilin through inhibition of TH2 responses in T cells and in a murine model of asthma. J. Agric. Food Chem. 60, 9405-9414 (2012).